|
05-29-2010, 03:53 PM
|
|||
|
|||
Bone drug from Amgen and Glaxo wins EU approval
Amgen's keenly awaited new drug Prolia, or denosumab, has been approved in Europe as a treatment for the brittle bone disease osteoporosis, the U.S. biotech giant said on Friday.
    
|
 |
| Thread Tools | |
| Display Modes | |
|
|
Similar Threads
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Amgen Drug Gets Priority Review For Bone Cancer | cancerfr | Bone Cancer | 0 | 07-17-2010 09:40 AM |
| Amgen seeks cancer approval for bone loss drug | cancerfr | Lung Cancer | 0 | 05-15-2010 02:24 PM |
| Amgen seeks cancer approval for bone loss drug | cancerfr | Bone Cancer | 0 | 05-15-2010 02:24 PM |
| BioDelivery Sciences drug wins second approval | cancerfr | Oral Cancer | 0 | 05-10-2010 02:23 PM |
Linear Mode
